|

Effectiveness of a School-centered Prevention Program on Prevalence of Latent Rheumatic Heart Disease

RECRUITINGN/ASponsored by Insel Gruppe AG, University Hospital Bern
Actively Recruiting
PhaseN/A
SponsorInsel Gruppe AG, University Hospital Bern
Started2022-06-01
Est. completion2026-06-01
Eligibility
Age5 Years – 16 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05504928

Summary

The overall objective is to evaluate the effectiveness of a school-centered primary and secondary prevention program on the prevalence of latent rheumatic heart disease among schoolchildren in Nepal, and to investigate the role of socioeconomic and environmental factors in the development and progression of rheumatic heart disease.

Eligibility

Age: 5 Years – 16 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age 5-16 years
* Attending Tulsi Secondary Boarding School in Tulsipur, Nepal.

Exclusion Criteria:

* Children / primary caregivers not providing informed consent to participate
* Children not attending Tulsi Secondary Boarding School in Tulsipur.

Conditions3

Heart DiseaseRheumatic Heart DiseaseRheumatic Heart Disease in Children

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.